Cramer Rosenthal Mcglynn LLC Omnicell, Inc Transaction History
Cramer Rosenthal Mcglynn LLC
- $1.38 Billion
- Q2 2025
A detailed history of Cramer Rosenthal Mcglynn LLC transactions in Omnicell, Inc stock. As of the latest transaction made, Cramer Rosenthal Mcglynn LLC holds 153,025 shares of OMCL stock, worth $4.63 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
153,025
Previous 220,276
30.53%
Holding current value
$4.63 Million
Previous $7.7 Million
41.58%
% of portfolio
0.33%
Previous 0.58%
Shares
12 transactions
Others Institutions Holding OMCL
# of Institutions
266Shares Held
47.1MCall Options Held
66.5KPut Options Held
0-
Black Rock Inc. New York, NY8.18MShares$248 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.64MShares$171 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.17MShares$65.5 Million0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$63.3 Million0.0% of portfolio
-
Lazard Asset Management LLC New York, NY1.71MShares$51.7 Million0.08% of portfolio
About OMNICELL, Inc
- Ticker OMCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 44,288,800
- Market Cap $1.34B
- Description
- Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...